Red Light Therapy for Women's Health: Research & Benefits

What Current Research Says 

Red light therapy for women's health refers to the use of low-level red and near-infrared light — a practice known clinically as photobiomodulation — as a complementary, non-invasive approach to common concerns like menstrual pain, postpartum recovery, and pelvic discomfort. It is not a treatment for any disease and does not replace medical care. Evidence quality varies sharply by condition: menstrual pain has reasonably strong clinical support, fertility and postpartum applications have early but encouraging trial data, and pregnancy-specific research is still too limited to draw firm conclusions.

Women's Health & Red Light Therapy: Evidence at a Glance

Women's Health Condition	Evidence Level	Potential Benefit
Menstrual pain (dysmenorrhea)	Moderate	May reduce pain intensity and frequency when used consistently before and during menstruation
Postpartum perineal recovery	Moderate	May reduce swelling and soreness faster than cryotherapy alone in early trials
Postpartum tailbone (coccydynia) pain	Emerging	May improve mobility and pain scores when combined with pelvic exercises
Fertility / IVF implantation support	Emerging	May support uterine receptivity in women with prior implantation failure; trends favorable but not yet statistically significant
Endometriosis-related pelvic pain	Limited to emerging	Small studies suggest pain reduction in general pelvic pain populations; endometriosis-specific data is sparse
Pregnancy (general use)	Limited	Theoretical benefits only; abdominal use is not recommended without medical guidance
Breast cancer supportive care	Limited, supportive context only	May support comfort and skin tolerance around treatment; not a cancer treatment and should never replace oncology care
Menopause symptom support	Limited	Indirect evidence from skin and mood research; no dedicated menopause trials

What Is Photobiomodulation?

Photobiomodulation is the scientific term for what most people call red light therapy. It involves exposing tissue to specific wavelengths of red (roughly 620–700 nanometers) and near-infrared (roughly 700–1000 nanometers) light, typically delivered through LED panels, wraps, or handheld devices.

The light itself doesn't heat tissue or cut it. Instead, it's absorbed by light-sensitive components inside mitochondria, the structures inside cells responsible for producing ATP, the molecule cells use as fuel. More available ATP means cells have more energy to carry out repair, regulate inflammation, and manage oxidative stress — the cellular wear and tear linked to many forms of tissue damage.

That's the mechanism in its simplest form. Where things get more complicated is in how reliably this translates into measurable outcomes for any specific condition, which is where the rest of this guide comes in.

Why Researchers Are Studying Red Light Therapy for Women's Health 

Most of the proposed benefits for women's health trace back to four overlapping processes: reduced inflammation, improved local circulation, modulation of pain signaling, and support for tissue repair.

Inflammation and tissue repair aren't the same thing, even though they're closely linked. Inflammation is the body's short-term response to injury or irritation — swelling, redness, immune cell activity. Tissue repair is what happens afterward, as cells rebuild what was damaged. Red light appears to influence both stages: some research points to a calming effect on excessive inflammatory signaling, while separate research shows increased collagen synthesis and cellular proliferation during the repair phase. A therapy that only reduced inflammation without supporting repair would be incomplete, and that distinction matters when conditions like postpartum tissue healing or menstrual cramping are being discussed.

Circulation matters because reproductive tissues — the uterine lining, ovarian tissue, pelvic muscles — depend on adequate blood flow for oxygen and nutrient delivery. Photobiomodulation research consistently shows improvements in local microcirculation, which is part of why it's been studied for endometrial receptivity and wound healing alike.

Pain signaling is a separate mechanism worth calling out specifically. Red light appears to influence how nerve endings transmit pain signals, independent of any anti-inflammatory effect. This is one reason it's been studied for conditions like menstrual cramping, where pain is driven partly by uterine muscle contractions and prostaglandin release rather than tissue damage alone.

Collagen production is most relevant to skin-related applications — stretch marks, scarring, postpartum skin changes — though its role is secondary to the categories above when discussing internal women's health conditions.

Why Do Different Wavelengths Matter?

Not all red light therapy studies use the same wavelengths, and that helps explain why results sometimes differ between clinical trials.

Red light wavelengths, generally between 620 and 700 nanometers, are absorbed more readily by superficial tissues such as the skin and areas close to the body's surface. Near-infrared wavelengths, typically between 700 and 1000 nanometers, penetrate more deeply and are often investigated for muscles, joints, and deeper connective tissues.

Researchers select wavelengths based on the biological target rather than using a single "best" setting for every condition.

For example:

• Around 630–660 nm is commonly studied for skin health, wound healing, and menstrual pain.
• Around 810–850 nm is frequently investigated for deeper tissues involved in musculoskeletal rehabilitation and some fertility protocols.
• Some clinical studies combine both red and near-infrared wavelengths to target tissues at multiple depths simultaneously.

Wavelength alone does not determine treatment success. Session duration, energy delivered, treatment frequency, and the condition being treated all influence outcomes, which is one reason studies cannot always be compared directly.

Women's Health Conditions That May Benefit

The conditions below span very different parts of a woman's life and very different bodies of evidence. Some, like primary dysmenorrhea, have had multiple controlled trials. Others, like pregnancy-specific use, have almost none. Reading across all of them side by side is useful precisely because it shows how uneven this field still is — strength of evidence is not the same from one condition to the next, and treating it as uniform would be misleading.

Where Does the Research Look Strongest?

One of the biggest misconceptions about red light therapy is that it has the same level of scientific support for every condition. It doesn't.

Some women's health applications have been investigated in multiple controlled clinical trials, while others are supported primarily by preliminary research or biological plausibility. Understanding these differences helps set realistic expectations and makes it easier to interpret new studies as they emerge.

Condition	Current Evidence	What Research Suggests
Menstrual pain	Moderate	Multiple clinical trials report meaningful reductions in pain intensity for many participants.
Postpartum recovery	Moderate	Early studies suggest improvements in tissue healing, swelling, and postpartum discomfort.
Fertility	Emerging	Small IVF studies report encouraging trends, but larger trials are still needed.
Endometriosis	Limited to Emerging	Evidence comes largely from broader pelvic pain research rather than endometriosis-specific studies.
Pregnancy	Limited	Human safety data remain insufficient to recommend routine use during pregnancy.
Breast cancer supportive care	Limited	Research focuses on symptom management and quality of life—not cancer treatment.
Menopause	Limited	Few studies have evaluated menopause-specific outcomes directly.

The sections below examine each condition individually, including what researchers know, what remains uncertain, and where red light therapy may fit alongside conventional medical care.

Menstrual Pain (Dysmenorrhea)

Primary dysmenorrhea, the clinical term for menstrual cramping not caused by an underlying condition, affects a substantial majority of menstruating women at some point. It remains one of the better-studied applications of red light therapy in women's health.

A controlled study using pulsed 630 nanometer red light, applied once daily for 20 minutes over seven days, followed 46 women aged 14 to 39 with moderate to severe menstrual pain. The results were notable: average pain scores dropped from 6.63 to 3.63 on a standard pain scale, with more than half of participants reporting at least a 50 percent reduction in pain. Most participants also said they preferred the active treatment over a placebo condition.

That's a meaningfully sized trial with a clear protocol, which puts menstrual pain ahead of most other applications discussed in this guide in terms of evidence quality. It still doesn't mean the treatment works the same way for everyone, or that results would replicate at scale. For a deeper breakdown of dosing, frequency, and how pulsed light compares to continuous light for this specific use, see our guide to pulsed red light therapy for menstrual cramps and our article on red light therapy for menstrual pain.

Endometriosis & Chronic Pelvic Pain

Endometriosis is a different category of problem than typical menstrual cramping. It involves tissue similar to the uterine lining growing outside the uterus, which can cause chronic pelvic pain, pain during ovulation, and other symptoms that often persist beyond the menstrual window itself.

The research picture here is thinner. There isn't a large body of endometriosis-specific red light therapy trials. What does exist is research on chronic pelvic pain more broadly — one cohort study found that close to 60 percent of women with chronic pelvic pain experienced a meaningful reduction in pain after nine LED therapy sessions. That's encouraging, but it's a study of pelvic pain in general, not endometriosis specifically, and the distinction matters because endometriosis pain has different underlying biology than pain from other causes.

Given how limited dedicated research is, red light therapy for endometriosis is best understood as a possible adjunct for symptom comfort rather than something with its own evidence base. Anyone managing endometriosis should treat it as one tool among several, not a primary strategy, and should stay engaged with a gynecologist, since endometriosis symptoms can mask or coexist with other conditions that need direct medical attention. Our guide on at-home approaches to endometriosis ovulation pain goes deeper into where light therapy fits alongside heat, diet, and other self-care strategies.

Fertility & IVF Support

Fertility is where the science starts to feel genuinely early-stage, but also where some of the more interesting controlled research has emerged.

Two small clinical trials looked specifically at women with recurrent implantation failure undergoing IVF. A 2020 study in Gynecological Endocrinology used helium-neon laser pretreatment before frozen embryo transfer in 60 women, comparing 30 who received the laser treatment against 30 who received standard care. The laser group showed higher implantation and clinical pregnancy rates, along with slightly higher live birth rates and lower miscarriage rates, though the differences did not reach statistical significance given the sample size.

A follow-up study in 2024, published in the Journal of Lasers in Medical Sciences, used 850 nanometer low-level laser therapy in 30 women with a similar history of implantation failure. Biochemical pregnancy rates were 46.7 percent in the laser group versus 33.3 percent in the control group, and clinical pregnancy rates were 33.3 percent versus 20 percent. Again, the trend favored the treatment group, but the sample size was too small to confirm statistical significance.

Why does fertility evidence lag behind something like menstrual pain research? Partly because trials involving IVF and pregnancy outcomes are expensive, slow, and ethically constrained in ways that pain studies aren't. Recruiting women already undergoing fertility treatment, tracking pregnancy outcomes over months, and accounting for the many variables that affect implantation success all make this a harder area to study quickly.

The proposed mechanism — improved microcirculation and reduced oxidative stress supporting a more receptive uterine lining — is biologically plausible and consistent with what's known about photobiomodulation elsewhere in the body. But plausible mechanisms and a couple of small trials with favorable trends are not the same as proof of effectiveness. Anyone using red light therapy as part of a fertility journey should treat it as a possible complement to medical fertility care, not a substitute for working with a reproductive endocrinologist or fertility specialist. Our in-depth article on red light therapy and fertility covers both studies in more detail, including study design and limitations.

Pregnancy: What We Know—and What We Don't

This is the area where caution matters most, and where the evidence gap is largest.

There is no body of clinical research evaluating red light therapy's safety or effectiveness specifically in pregnant women. The handful of pregnancy-adjacent studies that exist — including laboratory research on red light's effects on placental tissue in preeclampsia — were conducted outside the context of an ongoing human pregnancy and can't be generalized to general prenatal use.

That absence of evidence is exactly why recommendations stay conservative. It is not that researchers have found red light therapy harmful during pregnancy; it's that almost nobody has studied it directly in pregnant populations, and that gap alone is reason enough to proceed carefully. The general safety profile of red light therapy in non-pregnant adults doesn't automatically transfer to pregnancy, given how much physiology changes during gestation.

Direct application to the abdomen during pregnancy is not currently recommended outside of medical supervision. Any pregnant person considering red light therapy for non-abdominal discomfort, such as lower back pain, should talk with their OB-GYN or midwife first, since individual circumstances, gestational stage, and pregnancy complications all affect what's appropriate. For a full breakdown of current guidance, see our dedicated article on red light therapy during pregnancy and our safety-focused guide to red light therapy and pregnancy.

Supporting Postpartum Recovery

Postpartum recovery covers a wide range of physical changes: perineal healing after vaginal delivery, tailbone pain, pelvic floor weakness, and general soft tissue repair. This is one of the stronger evidence areas in this guide, helped by the fact that postpartum recovery timelines are short and well-defined, which makes for more feasible clinical trials than something like fertility or pregnancy.

A 2024 trial published in the European Journal of Obstetrics, Gynecology and Reproductive Biology compared photobiomodulation to cryotherapy (the standard cold-therapy approach) in 58 women within 12 hours of vaginal delivery, all of whom had grade I or II perineal lacerations or an episiotomy. The photobiomodulation group showed faster reductions in swelling and soreness compared to the cryotherapy group.

Separately, a 2025 study in Photobiomodulation, Photomedicine, and Laser Surgery looked at postpartum coccydynia — tailbone pain — in 60 participants, combining light therapy with pelvic floor exercises. The combination group showed greater improvements in mobility and pain compared to exercise alone.

Both studies point in a similar direction: red light therapy paired with standard postpartum care (rest, gentle movement, professional guidance) may support faster comfort and mobility than standard care alone. Neither study suggests it should replace medical follow-up, particularly for active wounds, complicated deliveries, or unresolved healing issues, all of which call for direct guidance from an OB-GYN, midwife, or physical therapist. Our full postpartum recovery guide walks through both studies and practical at-home application.

Supportive Care During Breast Cancer Treatment

This section is intentionally narrow. Red light therapy is not a cancer treatment, does not treat or shrink tumors, and should never be used as a substitute for oncology care.

Within that boundary, some research has explored whether photobiomodulation can support comfort and quality of life around the edges of cancer treatment — not the cancer itself, but the experience of going through treatment. This includes managing skin reactions from radiation, supporting wound healing after breast cancer surgery, and addressing general physical discomfort that can accompany treatment.

This remains a supportive and quality-of-life-focused area, not a treatment strategy, and any use during active cancer care should be discussed directly with the treating oncology team first, since certain treatment phases or medications may make light-based therapies inappropriate. For more detail on what current research does and doesn't say about supportive use, see our article on red light therapy and breast cancer supportive care.

Is Red Light Therapy Safe for Women?

Red light therapy is generally well tolerated, with a strong overall safety record in non-pregnant adults. It's non-invasive, doesn't involve UV radiation, and the most commonly reported side effect across studies is mild, temporary skin irritation. That said, safety isn't a single answer across every stage of a woman's life. A few situations call for extra care.

Situation	Recommendation
Pregnancy	Consult OB-GYN first
Fertility treatment	Discuss with fertility specialist
Breastfeeding	Ask healthcare provider before treating near the chest
Postpartum	Follow medical guidance if healing from delivery
Active medical conditions	Seek medical advice before starting

Across all of these situations, the same baseline applies: anyone with an active medical condition, a recent surgery, photosensitizing medication, or simply uncertainty about whether red light therapy is appropriate for their situation should talk with a healthcare provider before starting.

What Researchers Still Don't Know

Photobiomodulation has been studied for decades, but many women's health applications remain in the early stages of clinical research.

One challenge is that studies often use different wavelengths, treatment schedules, and outcome measures, making direct comparisons difficult. A protocol that shows promising results for menstrual pain may not be appropriate for fertility or postpartum recovery.

Many clinical trials have also enrolled relatively small numbers of participants. While these studies provide valuable early evidence, larger randomized trials are needed before stronger recommendations can be made for several conditions.

Researchers are currently investigating questions such as:

• Which wavelengths produce the most consistent results for different conditions?
• How frequently should treatments be performed?
• Which patients are most likely to benefit?
• How long do improvements last after treatment ends?
• Can photobiomodulation improve outcomes when combined with other therapies?

As this research grows, recommendations will likely become more specific. Until then, red light therapy is best viewed as an evolving area of supportive care rather than a universal solution for women's health concerns.

How to Use Red Light Therapy Safely at Home

Most home-use protocols in the research above followed a similar pattern: short sessions, used consistently, over a defined period rather than as a one-time treatment. Sessions in the menstrual pain study lasted 20 minutes daily for seven days; postpartum studies used treatment within hours of delivery and over the following days.

Consistency tends to matter more than intensity. Photobiomodulation works cumulatively at the cellular level, which is part of why single-session use rarely shows the same results as a structured, repeated routine.

Manufacturer guidelines on session length, distance from the device, and frequency exist for a reason and shouldn't be exceeded on the assumption that more light means faster results. Overuse hasn't been shown to provide additional benefit and is the most common cause of the mild skin irritation occasionally reported in studies.

It's also worth setting realistic expectations going in. None of the research summarized in this guide describes red light therapy as a cure or a guaranteed outcome. The studies with the strongest results — menstrual pain, postpartum perineal healing — still describe meaningful but partial improvement, not elimination of symptoms. Treating it as one supportive tool within a broader plan, rather than a standalone solution, matches what the evidence actually supports.

What This Means for Your Health Journey 

Photobiomodulation research in women's health sits in an unusual position right now. A handful of well-designed trials, particularly around menstrual pain and postpartum recovery, have produced genuinely encouraging results. Other areas, like fertility and endometriosis, have just enough early data to justify more research without yet supporting strong claims. And pregnancy remains almost entirely unstudied, which is its own kind of answer.

What's likely to change this picture over the next several years is larger trial sizes. Several of the studies referenced throughout this guide involved 30 to 60 participants — enough to detect a trend, not always enough to confirm it statistically. Larger, multi-site trials, particularly in fertility and endometriosis, would do more to clarify where this therapy genuinely helps and where current results may not hold up.

In the meantime, the most useful approach is also the most boring one: pay attention to which claims are backed by controlled studies and which are extrapolated from general photobiomodulation research, ask a healthcare provider when a personal medical situation adds complexity, and treat red light therapy as one tool among several rather than a replacement for established care. 

As larger clinical trials continue to emerge, recommendations will likely become more precise. Until then, the strongest approach remains the same: understand what the evidence supports today, recognize where uncertainty still exists, and use photobiomodulation as one part of a broader, evidence-based approach to women's health.